Lv71
3910 积分 2024-08-15 加入
Optimising posaconazole dosing in paediatric patients: a population pharmacokinetic modelling and simulation study
1小时前
求助中
Clinical hepatotoxicity associated with antifungal agents
27天前
已完结
Impact of body mass index and serum albumin levels on isavuconazole plasma concentrations in patients with haematological malignancies
1个月前
已完结
Isavuconazole prophylaxis and treatment in pediatric HSCT recipients: Pharmacokinetics, safety, and efficacy
2个月前
已完结
Metabolomic Profiling and Machine Learning‐Based Prediction of High‐Dose Methotrexate‐Induced Liver Injury in Pediatric Acute Lymphoblastic Leukemia
3个月前
已完结
Therapeutic Drug Monitoring–Driven Prediction of Cyclosporine-Associated Liver Injury in Pediatric Thalassemia After Hematopoietic Stem Cell Transplantation
3个月前
已完结
Isavuconazole as primary antifungal prophylaxis in pediatric hematological patients: a clinical and pharmacokinetic analysis
3个月前
已完结
Therapeutic Drug Monitoring–Driven Prediction of Cyclosporine-Associated Liver Injury in Pediatric Thalassemia After Hematopoietic Stem Cell Transplantation
3个月前
已关闭
Pharmacokinetic considerations of commonly administered antimicrobial agents in hematopoietic stem cell transplant patients
3个月前
已完结
Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole?
3个月前
已完结